Skip to main content
. 2022 Mar 22;2(4):839–852. doi: 10.1021/jacsau.1c00573

Table 3. Inhibition of SC2 Lentivector Entrya.

  Ib c (μM)c VE (%)d RV (%)e
1 4 10 46 ± 8 103
2 33 10 56 ± 12 107
3 11 50 4 ± 1 84
4 34 50 8 ± 6 76
5 35 50 25 ± 3 96f
6 45 50 31 ± 3 81
7 36 50 34 ± 3 97
8 3 50 36 ± 3 81
9 37 50 42 ± 32 97f
10 38 50 43 ± 26 37
11 39 50 52 ± 31 86f
12 40 50 64 ± 25 96f
13 46 50 65 ± 13 40f
14 47 50 83 ± 12 70
15 41 5 >100f 100
16 48 5 >100 94
17 49 5 >100 92
18 16 5 >100 89
19 42 10 97 ± 15 107
20 43 10 99 ± 12 87
21 44 10 103 ± 12 98
a

From normalized luminescence intensity of A549 human lung alveolar basal epithelium cells overexpressing ACE2 and TMPRSS2 after incubation with

b

inhibitor candidates at

c

concentrations c (1 h) and lentivirus with D614G SC2 spike protein (6 h), followed by 3 days for luciferase expression, reported as

d

vector entry (VE) in % (n = 3, ±SD).

e

RV: Relative cell viability. SD ≤ 10%.

f

SD > 10%.